Disruption of neurexin 1 associated with autism spectrum disorder.

By Hyung-Goo Kim, Shotaro Kishikawa, A. Higgins, I. Seong, D. J. Donovan, Yiping Shen, Eric Lally, L. Weiss, J. Najm, K. Kutsche and 16 more. American Journal of Human Genetics, 2008

602 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/0285d588f77ecbcc45a199732780aa69cab754a4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

1. Mark F. Bear
2. H. Zoghbi
3. Thomas Bourgeron

In Genetics

1. Mark F. Bear
2. H. Zoghbi
3. Andreas Buja
4. Abba M. Krieger
5. Thomas Bourgeron
6. Piotr Fryzlewicz

In Molecular Biology

1. H. Zoghbi
2. Mark F. Bear
3. Andreas Buja
4. Abba M. Krieger
5. Piotr Fryzlewicz

Citations in the corpus

• Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. (2012, background): “The first abnormalities involving NEUREXIN1 ( NRXN1 ) were identified in two individuals with ASD and balanced chromosomal abnormalities (Kim et al. 2008).”
• Rare de novo and transmitted copy-number variation in autistic spectrum disorders. (2011, positive): “For example, NRXN1 (encoding neurexin 1) is a well-established candidate gene underlying ASDs as well as schizophrenia (Ching et al., 2010; Kim et al., 2008; Pinto et al., 2010); the 44 kb deletion in family 12119 extends the number of known ASD-causing variants in the 2p16.”